<?php
/**
 * MinMaxMuscle Forum Topic Seed - Enlicitide
 * Generated: 2026-11-06
 *
 * To use: This script creates an Asgaros Forum topic via direct WP post insertion.
 * Run on the WordPress server or via WP-CLI:
 *   wp eval-file forum_pending/20261106_enlicitide.php
 *
 * NOTE: SSH not available from remote agent. Place this file on the server manually.
 */

if ( ! defined( 'ABSPATH' ) ) {
    // Allow direct WP-CLI execution
    define( 'ABSPATH', dirname(__FILE__) . '/' );
    require_once( '/var/www/html/wp-load.php' );
}

$post_data = [
    'post_title'   => 'Enlicitide (Lipfendra) — First Oral PCSK9 Peptide: FDA Approved July 2026 | Discussion',
    'post_content' => '<p><strong>Enlicitide (MK-0616, Lipfendra)</strong> became the first oral PCSK9 inhibitor approved by the FDA on July 16, 2026 — and it\'s a macrocyclic peptide, making it directly relevant to this community.</p>

<p><strong>What is it?</strong><br>
A macrocyclic peptide (~1,200 Da) that blocks PCSK9 from degrading LDL receptors on liver cells. More LDL receptors = more LDL cleared from blood. Same mechanism as injectable PCSK9 inhibitors (Repatha, Praluent) but in a once-daily oral tablet thanks to macrocyclization and sodium caprate co-formulation.</p>

<p><strong>Phase 3 CORALreef Lipids data (NEJM):</strong><br>
- 57% LDL-C reduction at week 24 (placebo-adjusted)<br>
- 2,909 participants on maximally tolerated statin therapy<br>
- Efficacy maintained through 52 weeks</p>

<p><strong>AHA 2026 (happening now, Nov 6-9, Chicago):</strong><br>
Oral PCSK9 inhibitor data and cardiovascular outcomes presentations ongoing at AHA this week.</p>

<p><strong>Key questions for the community:</strong></p>
<ul>
<li>Does an FDA-approved oral peptide open up new thinking about other peptides that might achieve oral bioavailability?</li>
<li>The macrocyclization + sodium caprate approach — are there other peptide compounds where this formulation strategy could work?</li>
<li>Cardiovascular outcomes trial (CVOT) is ongoing — anyone tracking when results are expected?</li>
<li>How does the 57% LDL reduction compare to what most statins achieve? (For reference, high-intensity statins typically reduce LDL 50-60%, so this is on par with the strongest statins.)</li>
</ul>

<p><strong>Research disclaimer:</strong> FDA-approved for hypercholesterolemia in adults as an adjunct to diet and maximally tolerated statin therapy. This is a prescription medication — discuss with your cardiologist/prescriber. Not for self-prescription.</p>

<p>Full research dossier: <a href="https://blog.minmaxmuscle.com/enlicitide-lipfendra-oral-pcsk9-macrocyclic-peptide-ldl-fda-approved-research-dossier/">Read the blog post</a> | <a href="https://minmaxmuscle.com/peptides/enlicitide">View peptide dossier</a></p>',
    'post_status'  => 'publish',
    'post_author'  => 1,
    'post_type'    => 'post',
    'meta_input'   => [
        '_asgaros_topic_forum_id' => 1,
    ],
];

$post_id = wp_insert_post( $post_data );

if ( is_wp_error( $post_id ) ) {
    echo 'Error creating forum topic: ' . $post_id->get_error_message() . "\n";
} else {
    echo 'Forum topic created for Enlicitide. Post ID: ' . $post_id . "\n";
}
